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Abstract
Background: The association between ischemic stroke and 2 single nucleotide polymorphisms (SNPs) on
chromosome 12p13, rs12425791 and rs11833579 appears inconsistent across different samples. These SNPs are
close to the ninjurin2 gene which may alter the risk of stroke by affecting brain response to ischemic injury. The
purpose of this study was to investigate the association between these two SNPs and ischemic stroke risk, as well
as prognostic outcomes in a Taiwanese sample.
Methods: We examined the relations of these two SNPs to the odds of new-onset ischemic stroke, ischemic stroke
subtypes, and to the one year risk of stroke-related death or recurrent stroke following initial stroke in a case-
control study. A total of 765 consecutive patients who had first-ever ischemic stroke were compared to 977 stroke-
free, age-matched controls. SNPs were genotyped by Taqman fluorescent allelic discrimination assay. The
association between ischemic stroke and SNPs were analyzed by multivariate logistic regression. Cox proportional
hazard model was used to assess the effect of individual SNPs on stroke-related mortality or recurrent stroke.
Results: There was no significant association between SNP rs12425791 and rs11833579 and ischemic stroke after
multiple testing corrections. However, the marginal significant association was observed between SNP rs12425791
and large artery atherosclerosis under recessive model (OR, 2.30; 95%CI, 1.22-4.34; q-value = 0.062). Among the 765
ischemic stroke patients, 59 died or developed a recurrent stroke. After adjustment for age, sex, vascular risk factors
and baseline stroke severity, Cox proportional hazard analysis indicated that the hazard ratios were 2.76 (95%CI,
1.34-5.68; q-value, 0.02) and 2.15 (95%CI, 1.15-4.02; q-value, 0.03) for individuals with homozygous variant allele of
rs12425791 and rs11833579, respectively.
Conclusions: This is a precedent study that found genetic variants of rs12425791 and rs11833579 on chromosome
12p13 are independent predictors of stroke-related mortality or stroke recurrence in patients with incident ischemic
stroke in Taiwan. Further study is needed to explore the details of the physiological function and the molecular
mechanisms underlying the association of this genetic locus with ischemic stroke.
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A genome-wide association study (GWAS) conducted by
the Cohorts for Heart and Aging Research Consortium
in Genetic Epidemiology (CHARGE) reported a novel
association between ischemic stroke and 2 single nucleo-
tide polymorphisms (SNPs) on chromosome 12p13,
rs12425791 and rs11833579, in a Caucasian sample [1].
The researchers further examined the association
between the two implicated SNPs and ischemic stroke in
two independent replication samples, an African-Ameri-
can community-based cohort and a Dutch case-control.
From both samples, they observed that rs12425791 was
significantly associated with the incidence of ischemic
stroke, particular in atherothrombotic stroke [1]. Never-
theless, the results of subsequent validated studies have
been inconsistent. The International Stroke Genetics
Consortium (ISGC) and the Wellcome Trust Case-Con-
trol Consortium 2 (WTCCC2) performed a meta-analysis
combining case-control data among European ancestry
and a population-based genomewide cohort study; how-
ever, the results were controversial [2]. In addition, an
Italian and a Swedish case-control study also failed to
s h o wa n ya s s o c i a t i o n sb e t w e e nt h et w og e n e t i cv a r i a n t s
on chromosome 12p13 and ischemic stroke [3,4]. Con-
versely, a large population-based case-control study
found a significant association between atherothrombotic
stroke and rs12425791 in Japan [5].
The 2 SNPs on chromosome 12p13, rs12425791 and
rs11833579 are in close proximity to the gene NINJ2,
which encodes ninjurin2, a member of the ‘ninjurin’ or
nerve-injury-induced protein family [6]. NINJ2 plays a
role in nerve regeneration and may increase the risk of
stroke by altering brain response to ischemic injury. If
this were true, the minor allele that increases stroke risk
would also be associated with greater stroke severity and
disability. In this case-control study, we investigated the
association between the two SNPs, rs12425791 and
rs11833579 and the risk of ischemic stroke among Tai-
wanese population who had first-ever ischemic strokes.
Furthermore, the study also examined whether the asso-
ciations between these two SNPs and end-point of
stroke-related mortality or recurrent stroke were
present.
Methods
Subject recruitment and study design
The study was conducted in the Formosa Stroke
Genetic Consortium (FSGC), a platform for hospital col-
laborations on studies related to the molecular biology
of cerebrovascular diseases. A standard FSGC operation
manual was developed after a series of consensus con-
ferences joining by an expert panel (5 stroke neurolo-
gists and 3 epidemiologists) and revised after a pilot
study completed in three hospitals (2 medical centers
and 1 regional hospital). All the research assistants and
study nurses from the participating hospitals were
trained on the standard procedure of case enrollment,
including structured questionnaire and blood sample
collection. The hospitals of FSGC have successfully
established the Taiwan Stroke Registry (TSR), which
provided a comprehensive insight into stroke manage-
ment [7]. Ten hospitals joined the FSGC between 2005
to 2010 (Additional file 1, section 1) and 1732 stroke
patients (84.3% ischemic, 5.5% transient ischemic attack
[TIA] and 9.6% hemorrhagic) were recruited from FSGC
hospitals and admitted to the Department of Neurology.
A m o n g1 4 6 0i s c h e m i cs t r o k ep a t i e n t s ,t h e r ew e r e1 1 0 3
(75.5%) first-ever stroke and 357 (24.5) recurrent stroke.
The criteria for the diagnosis of stroke have been
detailed in previous study [7]. Ischemic stroke is an
onset of focal neurological deficit with signs or symp-
toms persisted longer than 24 hours with or without
acute ischemic lesion(s) on brain CT or with acute
ischemic diffusion-weighted imaging lesion(s) on MRI
that corresponded to the clinical presentations. TIA is
defined as a transient focal neurologic deficit of
ischemic causes that resolved within 24 hours. The sub-
types of ischemic stroke were classified according to the
Trial of Org 10172 in Acute Stroke Treatment
(TOAST) criteria [8]. In the present case-control study,
the subjects were composed of 765 first-ever ischemic
stroke patients, who entered FSGC between 2005 and
2009. A total of 2736 healthy subjects were recruited as
possible controls from a community-based prospective
study of the nutrition health education program in Tai-
pei City [9] and subjects who underwent physical exami-
nations at TMUH during 2008-2009. Among these
participants, 53 subjects with prevalent stroke were
excluded. 977 age-matched controls were randomly
selected in the remaining 2683 candidates. The study
was approved by the ethics committees of the participat-
ing hospitals and Taipei Medical University on the
understanding that all data would be coded and patient
anonymity guaranteed. Informed consent was obtained
from all participants and/or their relatives.
The design of the present study constitutes a two-step
approach. In the primary analysis, we have conducted a
case-control study with 765 Taiwanese patients who had
first-ever ischemic stroke and 977 age-matched stroke-
free controls for the two SNPs, rs12425791 and
rs11833579 on chromosome 12p13. In the second step,
the analysis on the association between these two SNPs
and stroke-related mortality as well as stroke recurrent
events were restricted only to ischemic stroke patients.
Data collection
Data were collected from multiple centers as part of the
TSR and applied to the FSGC for the improvement of
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gists and study nurses collected preadmission data, inpa-
tient elements, discharge information, and follow-up at
1, 3, 6, and 12 months, an English translation of a sam-
ple form found in Additional file 1, section 2. Investiga-
tors who were in charge of assigning a National
Institutes of Health Stroke Scale (NIHSS) score had cer-
tified by the FSGC and trained to complete data entry
through a web-based FSGC database system. In healthy
controls, data on age, sex, and presence of major vascu-
lar risk factors were compiled by trained investigators
using a structured questionnaire. Subsequently, the data
were extracted from medical charts or self-reported dur-
ing interview under trained research assistants/nurses.
The definitions of risk factors were described in Addi-
tional file 1, section 3.
Outcome data acquirement
Mortality rates were ascertained based on death-certifi-
cate data recorded at the Department of Health, Execu-
tive Yuan of Taiwan. Data of recurrent stroke were
obtained in the history and examinations completed at
1, 3, 6, and 12 months follow-up in the FSGC data bank.
Genotyping
Genomic DNA was extracted using the phenol/chloro-
form method and then stored at -80°C until use. SNPs
were genotyped by Taqman fluorescent allelic discrimi-
nation assay with the ABI Prism 7900HT sequence
detection system (Applied Biosystems, Foster City, CA,
USA) Specific Taqman probes and primers were
obtained from Applied Biosystems Assay-by-DesignTM
service for SNP genotyping. The genotyping success rate
was greater than 98% for all SNPs. To assure data qual-
ity, we sequenced 5% of samples using the ABI 3100
DNA sequencer (Applied Biosystems). The genotype
concordance rate between duplicate samples was 100%.
Statistical analysis
Student’s t-test was used to compare continuous vari-
ables between cases and controls. The chi-square test
was applied to test differences in categorical variables.
Hardy-Weinberg equilibrium test for each SNP in
healthy controls and cases were also assessed by chi-
square analysis. To estimate the odds ratio (OR) and
95% confidence interval (CI), a multivariate logistic
regression was applied under the adjustment of potential
confounders. For each SNP, we tested for association
under additive, co-dominant dominant and recessive
models. The Cox proportional hazard model was used
to assess the effect of individual SNPs on survival, the
time of the stroke to the date of stroke-related death or
recurrence-free survival time, the time from initial
stroke occurrence to stroke recurrence. Hazard ratios
(HRs) and 95% CI were estimated by fitting the Cox
model while adjusting for stroke-related risk factors,
including age, sex, hypertension, diabetes, cigarette
smoking and alcohol drinking status, obesity and NIHSS
score at beginning. Kaplan-Meier curves and log-rank
tests were used to assess the differences in overall survi-
val and recurrence-free survival by individual poly-
morphisms. We performed random-effect meta-analysis
to pooled OR/HR and 95% CI across previous published
studies which explored the association between SNPs on
chromosome 12p13 and ischemic stroke [1-5]. All statis-
tical analyses were performed with SAS Genetics soft-
ware (version 9.1; SAS Institute, Cary, NC) or STATA
[10]. Two-tailed p values were calculated and statistical
significance was set at p-values < 0.05 nominally. To
account for multiple comparison, we calculated the false
discovery rate (FDR) using the Benjamini-Hochberg pro-
cedure and expressed using q-values [11].
Results
Table 1 illustrates the basic characteristics of the study
participants. The average ages of the ischemic stroke
patients and healthy controls were 62.8 ± 12.2 and 63.4
± 11.9 years, respectively. The distribution of gender
among cases and controls were similar. There were a
greater proportion of hypertensives, diabetics, smokers,
alcohol users, and subjects with heart disease in the
patient group compared with the controls. Mean BMI,
fasting glucose levels, and LDLC were higher in cases
than in controls while HDLC and cholesterol were
lower in cases compared to controls. Among the 765
ischemic stroke events, median NIHSS was 3. The
majority of them were due to small vessel occlusion
(SVO, 44.7%). Other ischemic stroke types in order of
frequency were large artery atherosclerosis (LAA,
26.8%), undetermined pathogenesis (14.0%), cardioem-
bolism (CE, 7.1%), and strokes due to specific rare etiol-
ogies such as dissection, moyamoya syndrome etc.
(2.6%). Genotype frequencies of SNP rs12425791 and
rs11833579 were listed and in HWE with c2t e s tp -
values > 0.05. The allele frequencies of both SNPs were
also shown in Table 1.
Associations between SNPs and different types of
ischemic stroke are shown in Table 2. After multiple
testing corrections, there was no significant association
between SNP rs12425791 and rs11833579 and ischemic
stroke. However, the marginal significant association
was observed between SNP rs12425791 and LAA under
recessive model. Table 3 compares the distribution of
rs12425791 and rs11833579 for patients with and with-
out death and/or recurrent stroke during a 1-year fol-
low-up period. Among 765 ischemic stroke patients, a
total of 59 events (7.7%) were recorded, including 21
stroke-related deaths and 40 recurrent stroke events.
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stroke patients. Ischemic stroke patients carrying the
rs12425791 GA (9.0%) and AA (18.0%) genotypes had
higher event rates for death and/or stroke recurrence
compared with participants with GG (5.8%) genotype (P <
0.05). Cox proportional model shown a significant associa-
tion was observed for rs12425791 AA versus GG homozy-
gote co-dominant model (HR, 3.30; 95%CI, 1.53-7.12;
Table 1 Characteristics of patients with first-ever ischemic stroke and healthy control subjects
Characteristic Cases (n = 765) Controls (n = 977) P-value
Age, mean (SD), y 62.8 ± 12.2 63.4 ± 11.9 0.526
Male, % 66.1 67.9 0.480
Hypertension, % 71.1 53.9 < 0.0001
Diabetes mellitus, % 43.2 16.1 < 0.0001
Heart disease, % 25.8 15.8 < 0.0001
Ever smoking, % 51.4 31.8 < 0.0001
Ever drinking, % 25.0 15.3 < 0.0001
Body mass index, mean (SD), kg/m
2 25.3 ± 3.9 24.7 ± 3.3 0.001
Fasting glucose, means (SD), mmol/L 6.9 ± 2.7 5.8 ± 1.7 < 0.0001
HDL-C, mean (SD), mmol/L 1.1 ± 0.4 1.3 ± 0.3 < 0.0001
LDL-C, mean (SD), mmol/L 3.3 ± 1.0 3.2 ± 0.8 0.024
Triglyceride, mean (SD), mmol/L 1.6 ± 1.1 1.5 ± 1.1 0.097
Cholesterol, mean (SD), mmol/L 5.0 ± 1.2 5.2 ± 0.9 0.005
NIHSS at baseline, median (IQR) 3(1-5)
TOAST, %
Large artery atherosclerosis 26.8
Small vessel occlusion 44.7
Cardioembolism 7.1
Specific pathogenesis 2.6
Undetermined pathogenesis 14.0
Missing 4.8
rs12425791, n(%)
GG 447(58.4) 557(57.4) 0.091
GA 268(35.0) 371(38.2)
AA 50(6.5) 43(4.4)
rs11833579, n(%)
GG 338(44.3) 433(44.9) 0.431
GA 325(42.6) 425(44.0)
AA 100(13.1) 107(11.1)
HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; NIHSS: National Institutes of Health Stroke Scale; TOAST: Trial of Org 10172
in Acute Stroke Treatment
Table 2 The odds ratios (ORs) of rs12425791 and rs11833579 genotypes for ischemic stroke
SNP Total ischemic stroke LAA
OR* 95% CI P-value q-value
† OR* 95% CI P-value q-value
†
rs12425791
Additive 1.00 (0.84-1.19) 0.977 0.977 1.03 (0.79-1.34) 0.831 0.997
Dominant 0.90 (0.72-1.11) 0.304 0.609 0.87 (0.63-1.19) 0.384 0.610
Recessive 1.67 (1.05-2.66) 0.031 0.183 2.30 (1.22-4.34) 0.010 0.062
rs11833579
Additive 1.01 (0.87-1.18) 0.860 0.977 1.00 (0.79-1.26) 0.999 0.999
Dominant 0.95 (0.77-1.17) 0.596 0.893 0.88 (0.64-1.20) 0.407 0.610
Recessive 1.21 (0.88-1.67) 0.241 0.609 1.35 (0.85-2.14) 0.200 0.599
*: adjustment for age, gender, hypertension, diabetes mellitus, heart disease, dyslipidemia, cigarette smoking or alcohol drinking, and obesity
†: False discovery rate (FDR) was controlled using the Benjamini-Hochberg procedure
LAA, large artery atherosclerosis
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1.08-3.08, q-value, 0.038), and for the recessive model
(HR, 2.76; 95%CI, 1.34-5.68; q-value, 0.018). There is a
similar tendency for the SNP rs11833579. In the sample of
59 events, 26 subjects are in the rs11833579 GA genotype
group (8.0%) and 14 subjects are in the AA genotype
group (14.0%). The prominently elevated risk was also
found in rs11833579 AA versus GG homozygote co-domi-
nant model (HR, 2.68; 95%CI, 1.31-5.48; q-value, 0.018)
and the recessive model (HR, 2.15; 95%CI, 1.15-4.02, q-
value, 0.034). The log-rank test shows a significant differ-
ence in event-free survival rates among patients with both
SNPs during a 1-year follow-up period (Figure 1). The
additional survival curve and log-rank test results were
showed in Additional file 1, section 4.
Discussion
The present study investigated the relationship between
the SNP rs12425791 and rs11833579 on chromosome 12
and ischemic stroke and poor prognosis. The results
showed there was a marginal significant association
between SNP rs12425791 and LAA under recessive
model. Previous studies concerning the relationship
between SNP rs12425791 and rs11833579 and ischemic
stroke were controversial. The GWAS finding and a large
Japanese case control study presents an association
between NINJ2 SNPs and ischemic stroke [1,5]. Although
we observed that the SNP rs12425791 and rs11833579
on chromosome 12 were not significantly associated with
ischemic stroke, the increased ischemic stroke risk trend
were found among subjects carried the homozygous var-
iant allele of these two SNPs. On the contrary, the results
from a meta-analysis performed by ISGC and WTCCC2
including samples of European ancestry, a small young
Italian case-control sample, and a recent report on 3
Swedish case-control samples did not find an association
[2-4]. The possible reasons for the difference might be
ethnicity (European Caucasian versus Asian) or study
design (incident/first-ever ischemic stroke versus preva-
lent stroke). However, different ethnicity is unlikely the
concern for different results since the chromosome
12p13 SNPs were significantly associated with ischemic
stroke in both European Caucasians and Asian [1,5]. In
addition, the MAF of SNP rs12425791 in our control
subjects (23.5%) was similar with Han Chinese in Beijing,
China (CHB) from the International HapMap project
(24%), and the samples of European ancestry in the
CHARGE (19%) [1], ISGC group (18-22%) [2] and the
Swedish population (16-19%)[4]. For SNP rs11833579,
the A allele frequency in the present study (32.9%) was
10% higher than in the CHARGE and ISGC group (23%)
[1,2], but was similar to the CHB (30%).
Concerning to study design, we performed a meta-
analysis combining results among all studies related to
Table 3 Survival analysis for rs12425791 and rs11833579 and risk of death or stroke recurrence among first-ever
ischemic stroke patients
SNP Neither death nor
stroke recurrence
observed (n = 706)
Either Death
or stroke
recurrence
(n = 59)
No. (%) No. (%) HR* (95% CI) P-value q-value‡
rs12425791
GG 421 (93.1) 26 (5.8) 1.0†
GA 244 (90.7) 24 (9.0) 1.55(0.88-2.74) 0.131 0.149
AA 41 (82.0) 9 (18.0) 3.30(1.53-7.12) 0.002 0.018
GG 421 (94.2) 26 (5.8) 1.0
GA+AA 285 (89.6) 33 (10.4) 1.83(1.08-3.08) 0.024 0.038
GG+GA 665 (93.0) 50 (7.0) 1.0
AA 41 (82.0) 9 (18.0) 2.76(1.34-5.68) 0.006 0.018
rs11833579
GG 319 (94.4) 19 (5.6) 1.0†
GA 299 (92.0) 26 (8.0) 1.53(0.84-2.80) 0.164 0.164
AA 86 (86.0) 14 (14.0) 2.68(1.31-5.48) 0.007 0.018
GG 319 (94.4) 19 (5.6) 1.0
GA+AA 385 (90.6) 40 (9.4) 1.80(1.03-3.13) 0.039 0.052
GG+GA 618 (93.2) 45 (6.8) 1.0
AA 86 (86.0) 14 (14.0) 2.15(1.15-4.02) 0.017 0.034
*: Adjusted for age, gender, hypertension, diabetes mellitus, cigarette smoking and alcohol drinking, obesity, and NIHSS at the beginning
†: p for trend < 0.05
‡: False discovery rate (FDR) was controlled using the Benjamini-Hochberg procedure
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first-ever ischemic stroke and prevalent stroke. The
results found that a significant association between both
SNPs on NINJ2 gene and ischemic stroke for
(rs12425791, OR, 1.20; 95%CI, 1.04-1.38; for
rs11833579, OR, 1.30; 95%CI, 1.10-1.54) among inci-
dent/first-ever ischemic stroke patients but not preva-
lent cases for (rs12425791, OR, 1.03; 95%CI, 0.99-1.07;
for rs11833579, OR, 1.03; 95%CI, 0.99-1.08) in Addi-
tional file 1, section 5. Survival bias might be the reason
for the lack of association between the SNPs and preva-
lent ischemic stroke. The result of meta-analysis might
also correspond to our data which indicate that patients
with the homozygous variant allele of these two SNPs
had an increased risk of adverse outcomes following
ischemic stroke. These two SNPs rs12425791 and
rs11833579, located on chromosome 12p13, are in close
proximity to the NINJ2 gene. Ninjurin 2 is a homophilic
adhesion molecule expressed in many tissues including
peripheral nerves, especially in Schwann cells and gang-
lion neurons [6,12]. It has been suggested that ninjurin
2, a nerve injury-induced protein, is involved in neuro-
nal growth and play a role in nerve regeneration since it
is up regulation during axotomy or nerve damage, pro-
moting neurite outgrowth [6,13]. It is possible that the
level of ninjurin 2 expression affects how the brain
responds to cerebral ischemic insults. In an analogous
manner, NINJ2 might be a candidate gene for stroke
prognosis since it may influence the reaction to brain
cells to injury. Our study found the initial NIHSS and
mRS was not correlated with NINJ2 gene based upon
genotype (data not shown), but further observed that
first-ever ischemic stroke patients with the variant allele
at these two SNPs had an increased risk of unfavorable
outcome. Moreover, when we analyzed the relative
change of modified Rankin Scale (mRS) during one year,
we also found that 2.7% of subjects were regression
(ΔmRS > 0) among patients with homozygous variant
allele of SNP rs12425791 while only 0.7% of subjects
with G allele became worse (data not shown). These evi-
dence support the hypothesis of our study that the
minor allele of NINJ2 gene might be related to greater
stroke severity.
Several published studies following by the original
research articles have encountered some limitations in
sample size, multiple testing, population stratification,
or publication bias [14,15]. In this study, a post hoc
power calculation was done based on the survival
probability were 10% and 5.6% among the variant allele
carriers and the subjects with wild allele, respectively.
The present sample size can reach to more than 80%
power to detect both SNPs with the concluded genoty-
pic HRs at the nominal Type I error rate less than
0.05. Also, we applied the false discovery rate method
as multiple testing to prevent the false-positive associa-
tion. Population stratification and publication bias may
also lead to false-positive association. However, the
limited evidence supports that population stratification
and public bias is a minor issue for genetic association
studies [16,17].
Figure 1 Relationship between rs12425791 and rs11833579 and risk of death and/or recurrent stroke in additive and recessive
models. (a) rs12425791 under additive model. (b) rs12425791 under recessive model. (c) rs11833579 under additive model. (d) rs11833579 under
recessive model.
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stroke patients in our study had accurate diagnosis con-
firmed by CT/MRI. We also examined the association
between SNPs and various subtypes of ischemic stroke
based on the abundant ancillary information in the
FSGC data bank. Moreover, the mean time interval
between stroke onset and entry was remarkably short
and completed in less than one day (mean+SD: 0.89 ±
1.70), thus reduced survivor bias, a significant problem
in most stroke case series utilized for genetic analyses.
Finally we could adjust our analyses for initial stroke
severity since the NIHSS was administered in all cases
prior to initiation of intravenous thrombolysis or other
stroke therapies. However, there were some limitations
in this study. Survival after stroke could depend on fac-
tors other than stroke severity, such as concomitant car-
diac and respiratory disease. We have not examined the
possible ranges of pleiotropic associations on the NINJ2
SNPs. In addition, the haplotype analysis of these two
SNPs were not showed due to low linkage disequili-
brium (r
2 = 0.53). According to the basis of the Hapmap
data, the correlation coefficients were similar among
Japanese populations (r
2 = 0.69). The identified SNP
rs12425791 is more likely to be in linkage disequilibrium
with the causal variants. Therefore, further detailed fine-
mapping or re-sequencing in the region will be needed
to identify the actual causal genetic variants.
Conclusions
This study provides the first evidence that chromosome
12p13 are an independent predictor of mortality or
stroke recurrence in patients with incident ischemic
stroke in Taiwan. Further study is needed to explore the
details of the physiological function and the molecular
mechanisms underlying the association of this genetic
locus with ischemic stroke.
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